Nothing Special   »   [go: up one dir, main page]

US3075527A - Sterile medicated strips - Google Patents

Sterile medicated strips Download PDF

Info

Publication number
US3075527A
US3075527A US33510A US3351060A US3075527A US 3075527 A US3075527 A US 3075527A US 33510 A US33510 A US 33510A US 3351060 A US3351060 A US 3351060A US 3075527 A US3075527 A US 3075527A
Authority
US
United States
Prior art keywords
medicament
strip
eye
tears
impregnated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US33510A
Inventor
Arthur W Bechtold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooper Laboratories Inc
Original Assignee
Chemway Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemway Corp filed Critical Chemway Corp
Priority to US33510A priority Critical patent/US3075527A/en
Application granted granted Critical
Publication of US3075527A publication Critical patent/US3075527A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Definitions

  • an ophthalmic applicator which in its preferred form is an elongated, flat strip of soft fabric, a part of which is impregnated with a dry medicament miscible with tears.
  • a preferred method of making the applicator is to apply a suitable quantity of a medicament solution of selected concentration to a soft textured, bibulous filter paper, dry it in warm air, seal it in an envelope, and sterilize it.
  • the absorbent strip is varnished at one end and the medicament is applied only to the other. The varnish is dried before the medicament is applied.
  • the medicament is applied as a solution of selected strength to the unvarnished part of the strip and the solution is dried leaving the paper impregnated with dry medicament.
  • the medicament used is preferably of such nature that it is soluble in tears and in such common solvents as water or alcohol.
  • These small strips, for instance 2" long x wide may have rounded and noticed ends and may be packaged in small polyethylene envelopes and sterilized. Sterilization is preferably done by the ethylene oxide method, as described in my copending application Serial No. 679,196 now Patent No. 3,032,182.
  • Example I The paper to be used in preparing these medications is a highly absorbent, soft textured, bibulous filter paper which is varnished on both sides almost to the tip to prevent the distribution of the introduced solution throughout its length by capillary action.
  • the varnish may be of any type but especially of neutral, quick drying resinous type, such as Bakelite. This paper then is die-cut to a narrow strip which is notched on one end.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Description

Jan; 29', 1963 A. w. BECHTOLD ,0
STERILE MEDICATED STRIPS Filed June 2, 1960 IMPREGNATED, NOTCHED END VARNISHED END IN V EN TOR.
ARTHUR W. BECHTOLD 3am Ma ATTORN S 3,075,527 STERILE MEDIQATED STRIPS Arthur W. Bechtold, Isiip, N.Y., assignor, by mesne assignments, to Chernway Corporation, Wayne, N.J., a corporation of Delaware Filed dune 2, 1969, Ser. No. 33,510 7 Claims. (Cl. 12826t This invention relates to the treatment of the eyes and particularly to a new carrier of medicament, to a method of making it, and to a novel method of introducing a medicament to the eye. The invention is particularly useful when it is desired to introduce to the eye a very small quantity of medicament, for instance less than one drop.
One object of this invention is to prepare medicaments in a sterile, solid form adapted to immediate use.
Another object is to provide medicated applicators which require no instruments for application.
Another object is to avoid the use of liquid in the treatment of the eye.
Another object is to prepare a novel applicator for ophthalmic medicaments soluble in tears.
Another object is to apply dry medicaments to the eye in the treatment of ophthalmic diseases.
The standard method of applying medicament to the eye is to use a dropper. This requires a bottle for the medicament, a stopper which is handled, a dropper, a container for the dropper and sometimes a sterilizer or a sterilizing solution for the sterilization of the dropper. The use of the dropper is not altogether satisfactory when very small quantities or" medicament are to be applied, for instance less medicament than would be included in one or two drops. In some cases the carrier liquid is irritating and it is desirable to apply the medicament in a dry state. After a bottle is opened, the contents are sometimes regarded as not sterile, resulting in the loss of expensive medicament.
The objects of the invention are accomplished, generally speaking, by an ophthalmic applicator which in its preferred form is an elongated, flat strip of soft fabric, a part of which is impregnated with a dry medicament miscible with tears. A preferred method of making the applicator is to apply a suitable quantity of a medicament solution of selected concentration to a soft textured, bibulous filter paper, dry it in warm air, seal it in an envelope, and sterilize it. In preferred cases the absorbent strip is varnished at one end and the medicament is applied only to the other. The varnish is dried before the medicament is applied. The medicament is applied as a solution of selected strength to the unvarnished part of the strip and the solution is dried leaving the paper impregnated with dry medicament. The medicament used is preferably of such nature that it is soluble in tears and in such common solvents as water or alcohol. After the strip has been dried it is cut by sterile means into small strips, each of which includes a quantity certain of medicament, for instance the dried content of one, two or more drops. These small strips, for instance 2" long x wide may have rounded and noticed ends and may be packaged in small polyethylene envelopes and sterilized. Sterilization is preferably done by the ethylene oxide method, as described in my copending application Serial No. 679,196 now Patent No. 3,032,182.
Example I.The paper to be used in preparing these medications is a highly absorbent, soft textured, bibulous filter paper which is varnished on both sides almost to the tip to prevent the distribution of the introduced solution throughout its length by capillary action. The varnish may be of any type but especially of neutral, quick drying resinous type, such as Bakelite. This paper then is die-cut to a narrow strip which is notched on one end.
I 3,075,527 Patented Jan. 29, 1963 The absorbent end is exposed to one drop of medication for instance containing .125 mg. of tetracaine hydrochloride, introduced by either a mechanized syringe capable of dispensing one drop at a time, pipetting manually, or dipping in a solution. The strips are dried in warm air-current and packaged individually in a transparent bag such as described in my copending case which would admit and maintain sterility. The ready strip is sterilized in ethylene oxide. Materials other than paper, that have absorbing qualities, may be used instead of paper strips i.e. gauze, and fabrics but they should be lintless and soft.
In use a sterile package containing a medicated strip is opened, the medicated strip is taken by its varnished end, and the soft, medicament-impregnated end of the strip is tucked inside the eyelid, for instance inside the lower lid where the medicament, being soluble in tears, is absorbed and distributed by the tears of the eye to the places which require treatment.
Typical of the medicaments which can be applied in this Way are homatropine HBr, atropine sulfate, pilocarpine HCl, eserine salicylate, carbamylcholine chloride, and tetracaine HCl.
In place of the filter paper there can be used any soft absorbent material, that is to say, any material which is acceptable to the eye without too much irritation, which will absorb an adequate quantity of medicament solution such as soft cotton or linen fabrics, and synthetics such as woven strands of inert plastic threads. The shape of the applicator can be as desired being rounded, notched, or any other convenient shape at the end which is to be inserted in the eye. It is unnecessary to varnish the strip although varnish, or a high size, or lacquering has the advantage of limiting the penetration of the medicament solution into the paper and of preventing moisture on the hands of the physician from travelling through the fabric to the medicated end. impregnation by means of water solution of the drug is satisfactory, but alcoholic solutions may also be used for impregnation and have the advantage of drying faster.
In some instances it is desirable to include in the solution a small amount of visible indicator, examples of which are rose bengal and fiuorescein sodium, so that the physicians may be able to estimate how much of the medicine will be absorbed by tears. By observing the color of the tears as they dissolve the medicine a reasonable estimation can be made of the quantity of medicine which has been taken. In what may be considered standard practice, it is satisfactory to include up to 3 mg. of such dyes in the impregnated end of the strip.
In impregnating as in Example I one may assume that 20 drops equal 1 cc. and make up solutions that contain in one drop the following quantities of medicament.
Amt. Percent Present,
One Drop 525 include in a solution that quantity of the desired medicament which will deposit the quantity of medicament desired in the applicator.
Example II.A paper strip 1 /2 wide, 1 long and made of soft filter paper was varnished on both sides except for a strip Wide along one long edge. A solution of atropine sulfate was made up to contain 0.125 mg. of medicament per drop. Drops of the solution were placed 4 apart on the exposed edge of the filter paper and allowed to dry in warm air. The strip was cut apart between the drops producing 48 small strips each of which contained about 0.125 mg. of the medicament. Each of these small strips was placed in a small envelope of polyethylene which was sealed thereafter. The sealed strips were placed in the autoclave which was closed and filled with ethylene oxide in a non-explosive concentration. The ethylene oxide penetrated the polyethylene envelope and sterilized the contents. In using the strip the doctor opened the envelope at the varnished end of the strip, removed the strip from the envelope, and immersed it in the tears of the eye gathered in the lower lid. The medicament, being soluble in tears was dissolved out of the strip and carried throughout the eye.
Air drying was used in drying the impregnated paper in this example, but in general drying will be carried out at elevated temperatures under reasonably sterile conditions. Absolute sterilization of impregnation and drying is not necessary where the strips are to be sterilized after packaging. In some cases, where it is desirable to have greater concentrations of medicament than can readily be applied in a single drop, repeated impregnations and dryings may be resorted to. Where a greater concentration of medicament is desired in the tears than can be obtained from a single strip, the physician can apply more than one strip.
In each instance the envelope containing the applicator strip will be labeled with the name and quantity oi medicament carried.
The advantages of the invention are in the accomplishving of the objectives of the invention. There are other advantages, for instance over the application of medicaments by the dropper. The quantity of liquid which the eye can retain is small and the addition of more than that limited quantity achieves no purpose, but material variations in the quantity of medicines usefully employable in the eye can be achieved by dissolving the medicine from more than one strip into the tears of the eye, thus increasing the concentration.
The necessity of keeping bottles of solutions at various strengths is. avoided. Also, the danger of breakage and spillage is lessened. Furthermore, the use of a medicament in liquid form increases the volume of fiuid in the eye causing the excess liquid to flow out of the eye and the medicament, already diluted in liquid form; is further diluted in its concentration when it is inserted into the eye fluids. This invention avoids all these problems he cause the medicament in the concentrated dry form utilizes the eye fluids to form the medicament in concentrated liquid form. There is thus no increase in the amount of fluid in the eye to cause the eye fluids to overflow and there is no dilution of the medicament concentration by the eye fluids themselves.
The accompanying drawing is a diagrammatic representation of a notched strip of filter paper one end of which has been varnished and the other impregnated with a quantity of medicament.
As many apparently widely different embodiments of the present invention may be made without departing from the spirit and scope thereof, it is to be understood that the invention is not limited to the specific embodimerits.
What is claimed is:
1. A medicated ophthalmic applicator comprising an elongated, fiat, thin, absorbent, soft, bibulous filter paper strip having a portion shaped for admission to the eye and impregnated with a dry ophthalmic medicament miscible with tears.
2. The applicator of claim 1 in which the impregnated portion of the strip also contains an indicator.
3. The applicator of claim 1 in which the ophthalmic medicament is selected from the group consisting of homatropine HBr, atropine sulfate, pilocarpine HCl, Eserine salicylate, carbamylcholine chloride, and tetra came.
4. The applicator of claim 1 in which the impregnated portion of the strip carries the ophthalmic medicament in an amount equivalent to about 0.125 to 2 mg. of the medicament.
5. A medicated ophthalmic applicator comprising an elongated, flat, thin, absorbent, soft, bibulous filter paper strip having a stifiened, non-absorbent portion convenient for handling, and an absorbent portion shaped for admission to the eye impregnated with a dry ophthalmic medicament miscible with tears.
6. A medicated ophthalmic applicator comprising an elongated, fiat, thin, absorbent, soft, bibulous filter paper strip having a rounded and notched portion for admission to the eye impregnated with a dry ophthalmic medicament miscible with tears.
7. A medicated ophthalmic applicator comprising an elongated, flat, thin, absorbent, soft, bibulous filter paper strip varnished throughout a substantial port of its length, and a rounded and notched unvarnished part for admission to the eye impregnated with a dry medicament miscible with tears.
References fitted in the file of this patent UNITED. STATES PATENTS 1,687,472 Dorman et a1. Oct. 9, 1928 2,702,780 Lerner Feb. 22, 1955 2 ,703,777 Feinstein et a1. Mar. 8, 1955

Claims (1)

1. A MEDICATED OPHTHALMIC APPLICATOR COMPRISING AN ELONGATED, FLAT SOFT, BIBULOUS FILETR PAPER STRIP HAVING A PORTION SHAPED FOR ADMISSION TO THE EYE AND IMPREGNATED WITH DRY OPHTHALMIC MEDICAMENT MISCIBLE WITH TEARS.
US33510A 1960-06-02 1960-06-02 Sterile medicated strips Expired - Lifetime US3075527A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US33510A US3075527A (en) 1960-06-02 1960-06-02 Sterile medicated strips

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33510A US3075527A (en) 1960-06-02 1960-06-02 Sterile medicated strips

Publications (1)

Publication Number Publication Date
US3075527A true US3075527A (en) 1963-01-29

Family

ID=21870808

Family Applications (1)

Application Number Title Priority Date Filing Date
US33510A Expired - Lifetime US3075527A (en) 1960-06-02 1960-06-02 Sterile medicated strips

Country Status (1)

Country Link
US (1) US3075527A (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678151A (en) * 1969-07-25 1972-07-18 Gugol Clini Tex Inc Biological staining method
US3828777A (en) * 1971-11-08 1974-08-13 Alza Corp Microporous ocular device
US3863633A (en) * 1971-06-04 1975-02-04 Pharmacia Ab Composition containing a substance showing a topical effect on the eye, and a method of preparing the same
US3870791A (en) * 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US4540408A (en) * 1981-04-30 1985-09-10 Smith And Nephew Associated Companies Limited Applicators for pharmacologically active agents, their preparation and use
US4778457A (en) * 1986-11-06 1988-10-18 York Kenneth K Disposable applicator
US5928662A (en) * 1996-07-31 1999-07-27 Phillips; Andrew F. Ocular drug delivery device
WO2000069506A1 (en) * 1999-05-18 2000-11-23 Ocular Research Of Boston, Inc. Method for instilling a controlled dose of fluid into the eye
EP1104263A1 (en) * 1998-08-12 2001-06-06 Ocular Research of Boston, Inc. Measurement of tear film break-up-time
EP1332754A1 (en) * 2002-01-31 2003-08-06 Daniel Mojon Material-releasing carrier
US20030225381A1 (en) * 2002-05-30 2003-12-04 Van Dalen Johan T.W. Apparatus and method for delivering controlled quantities of one or more agents to the eye
EP1407732A1 (en) * 2002-10-08 2004-04-14 Michael Dr. Horstmann Eye applicable device for secure dosage of systemic and topic medication
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
US9510972B2 (en) 2012-01-04 2016-12-06 Sight Sciences, Inc. Dry eye treatment systems
US9724230B2 (en) * 2012-01-04 2017-08-08 Sight Sciences, Inc. Dry eye treatment apparatus and methods
WO2018017873A1 (en) 2016-07-20 2018-01-25 Ryan Edwin Eye drop applicator and method
JP2018518514A (en) * 2015-06-26 2018-07-12 コンティプロ アクチオヴァ スポレチノスト Ophthalmic pharmaceutical composition
US10414832B2 (en) 2015-06-26 2019-09-17 Contipro A.S Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
US10618984B2 (en) 2016-06-27 2020-04-14 Contipro A.S. Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof
US10759878B2 (en) 2015-06-15 2020-09-01 Contipro A.S. Method of crosslinking of polysaccharides using photoremovable protecting groups
US10973680B2 (en) 2012-01-04 2021-04-13 Sight Sciences, Inc. Controller for dry eye treatment systems
US11141348B2 (en) 2018-02-26 2021-10-12 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders
US11285040B2 (en) 2012-01-04 2022-03-29 Sight Sciences, Inc. Combination treatment systems

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1687472A (en) * 1927-07-22 1928-10-09 Johnson & Johnson Emergency applicator and method of producing it
US2702780A (en) * 1950-10-10 1955-02-22 Phil Kalech Measuring dispensing sheet for germicides and process of forming same
US2703777A (en) * 1950-05-02 1955-03-08 Iso Sol Company Inc Ophthalmological preparations and vehicles and method of making the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1687472A (en) * 1927-07-22 1928-10-09 Johnson & Johnson Emergency applicator and method of producing it
US2703777A (en) * 1950-05-02 1955-03-08 Iso Sol Company Inc Ophthalmological preparations and vehicles and method of making the same
US2702780A (en) * 1950-10-10 1955-02-22 Phil Kalech Measuring dispensing sheet for germicides and process of forming same

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678151A (en) * 1969-07-25 1972-07-18 Gugol Clini Tex Inc Biological staining method
US3863633A (en) * 1971-06-04 1975-02-04 Pharmacia Ab Composition containing a substance showing a topical effect on the eye, and a method of preparing the same
US3828777A (en) * 1971-11-08 1974-08-13 Alza Corp Microporous ocular device
US3870791A (en) * 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US4540408A (en) * 1981-04-30 1985-09-10 Smith And Nephew Associated Companies Limited Applicators for pharmacologically active agents, their preparation and use
US4778457A (en) * 1986-11-06 1988-10-18 York Kenneth K Disposable applicator
US5928662A (en) * 1996-07-31 1999-07-27 Phillips; Andrew F. Ocular drug delivery device
US6159189A (en) * 1998-08-12 2000-12-12 Ocular Research Of Boston, Inc. Method for instilling a controlled dose of fluid into the eye
EP1104263A1 (en) * 1998-08-12 2001-06-06 Ocular Research of Boston, Inc. Measurement of tear film break-up-time
EP1104263A4 (en) * 1998-08-12 2008-11-19 Ocular Res Of Boston Inc Measurement of tear film break-up-time
WO2000069506A1 (en) * 1999-05-18 2000-11-23 Ocular Research Of Boston, Inc. Method for instilling a controlled dose of fluid into the eye
EP1332754A1 (en) * 2002-01-31 2003-08-06 Daniel Mojon Material-releasing carrier
US20030225381A1 (en) * 2002-05-30 2003-12-04 Van Dalen Johan T.W. Apparatus and method for delivering controlled quantities of one or more agents to the eye
US7018646B2 (en) 2002-05-30 2006-03-28 Van Dalen Johan T W Apparatus and method for delivering controlled quantities of one or more agents to the eye
EP1407732A1 (en) * 2002-10-08 2004-04-14 Michael Dr. Horstmann Eye applicable device for secure dosage of systemic and topic medication
US10772758B2 (en) 2012-01-04 2020-09-15 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US9642743B2 (en) 2012-01-04 2017-05-09 Sight Sciences, Inc. Methods for improving contact lens comfort
US9724230B2 (en) * 2012-01-04 2017-08-08 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US9844459B2 (en) 2012-01-04 2017-12-19 Sight Sciences, Inc. Dry eye treatment systems
US11285040B2 (en) 2012-01-04 2022-03-29 Sight Sciences, Inc. Combination treatment systems
US10973680B2 (en) 2012-01-04 2021-04-13 Sight Sciences, Inc. Controller for dry eye treatment systems
US10052226B2 (en) 2012-01-04 2018-08-21 Sight Sciences, Inc. Dry eye treatment systems
US10925765B2 (en) 2012-01-04 2021-02-23 Sight Sciences, Inc. Dry eye treatment systems
US9510972B2 (en) 2012-01-04 2016-12-06 Sight Sciences, Inc. Dry eye treatment systems
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof
US10759878B2 (en) 2015-06-15 2020-09-01 Contipro A.S. Method of crosslinking of polysaccharides using photoremovable protecting groups
US10414832B2 (en) 2015-06-26 2019-09-17 Contipro A.S Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
JP2018518514A (en) * 2015-06-26 2018-07-12 コンティプロ アクチオヴァ スポレチノスト Ophthalmic pharmaceutical composition
US10618984B2 (en) 2016-06-27 2020-04-14 Contipro A.S. Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof
WO2018017873A1 (en) 2016-07-20 2018-01-25 Ryan Edwin Eye drop applicator and method
EP3487480A4 (en) * 2016-07-20 2019-07-24 Ryan, Edwin Eye drop applicator and method
US20190183675A1 (en) * 2016-07-20 2019-06-20 Edwin Ryan Eye drop applicator and method
US11141348B2 (en) 2018-02-26 2021-10-12 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders
US11147737B2 (en) 2018-02-26 2021-10-19 Olympic Ophthalmics, Inc. Handheld device with motorized member for treatment of disorders
US11147735B2 (en) 2018-02-26 2021-10-19 Olympic Ophthalmics, Inc. Therapeutic handheld devices for disorders
US11147736B2 (en) 2018-02-26 2021-10-19 Olympic Ophthalmics, Inc. Therapeutic handheld devices for disorders
US11318066B2 (en) 2018-02-26 2022-05-03 Olympic Ophthalmics, Inc. Handheld device with vibrational cantilever member for treatment of disorders
US11801197B2 (en) 2018-02-26 2023-10-31 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders
US12016819B2 (en) 2018-02-26 2024-06-25 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders

Similar Documents

Publication Publication Date Title
US3075527A (en) Sterile medicated strips
DE69728280T2 (en) APPLICATOR FOR CHLOROHEXIDING LUCONATE (CHG) - SINGLE DOSE WITH EXTENDED DURABILITY
US4437567A (en) Sterile package and method of making
US2102858A (en) Capsule for storing fluids
US6343717B1 (en) Pre-filled disposable pipettes
US4486488A (en) Composition for the production of bandages, bandages produced therewith and method for the production thereof
US3043067A (en) Suture package
US10974037B2 (en) Device for the preparation and application of a medical substance
EP0081438A2 (en) Adhesive bandage
US3194237A (en) Pronged vaccinating and testing needle
GB669265A (en) Improvements in method and means for preserving small doses of biological and like liquids
CA2642435A1 (en) Sterile kit containing silicone gel for stereotaxy
US3474789A (en) Flexible ampoule
US2128701A (en) Method and apparatus for preserving sterile suture material for medicinal purposes ready for use
US3086647A (en) Dispensing package
CA1164412A (en) Disposable swab articles and other like articles
US1309201A (en) Planoqeaph co
US4357935A (en) Dry method of making a dry socket dressing
US2142707A (en) Ligature or suture package
US2813623A (en) Package and process
US3857677A (en) Method of sterile packaging
PT645081E (en) DEVICE FOR CARRYING OUT INSECTICIDAL TREATMENTS AND USING IT IN A ROOM
CN211884254U (en) Portable wet or dry cotton swab
US10426704B2 (en) Pre-dosed applicators and packaging therefor
CN208307449U (en) A kind of wet tissue